Supernus Announces Second Quarter 2015 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/25/2026
- Nasdaq futures jump 2% as Micron, Qualcomm forecasts ease AI concerns; PCE data awaited
- Micron posts record profit as AI memory demand fuels explosive growth
- Brent settles at lowest since before start of Iran war as more tankers exit Hormuz
- IBM surges on unveiling sub-1nm chip technology breakthrough
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
Supernus Pharmaceuticals (SUPN) Tops Q2 EPS by 1c, Updates Guidance
August 5, 2015 8:24 AM EDTSupernus Pharmaceuticals (NASDAQ: SUPN) reported Q2 EPS of $0.03, $0.01 better than the analyst estimate of $0.02. Revenue for the quarter came in at $35.1 million versus the consensus estimate of $34.27 million.
Financial Guidance
The Company is updating its full year 2015 financial guidance for both expected net... More
